Aker BioMarine AS reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was USD 79 million compared to USD 75.7 million a year ago. Net income was USD 0.2 million compared to net loss of USD 8.4 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.3 NOK | -1.79% | +0.56% | +55.00% |
Apr. 26 | Aker BioMarine AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 26 | Transcript : Aker BioMarine AS, Q1 2024 Earnings Call, Apr 26, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.00% | 566M | |
+12.78% | 3.29B | |
-95.58% | 1.61B | |
-0.48% | 1.61B | |
-2.37% | 1.25B | |
-2.40% | 1.22B | |
-.--% | 1.22B | |
-11.54% | 1.21B | |
-10.44% | 1.2B | |
0.00% | 1.19B |
- Stock Market
- Equities
- AKBM Stock
- News Aker BioMarine
- Aker BioMarine AS Reports Earnings Results for the Fourth Quarter Ended December 31, 2022